The BioPharm Brief: Oncology Innovations Continue with Durable Survival, In Vivo CAR-T, and Combination Therapies

Welcome to The BioPharm Brief, your daily snapshot of the latest developments shaping biopharmaceutical research, clinical progress, and regulatory strategy. Today’s update highlights advances in oncology across rare cancers, immunotherapy combinations, and strategic acquisitions aimed at next-generation cell therapy platforms.